SmithKline survives patent loss; The Investment Column

Despite early prognostications of doom, SmithKline Beecham, the drugs giant, has prospered since Tagamet, its blockbuster anti-ulcer drug, went off patent in 1993. As Jan Leschly, the group's well-rewarded chief executive, boasted yesterday, all the numbers are moving in the right direction.

The huge debts taken on in 1994 to buy first Diversified Pharmaceuticals, the US "pharmacy benefit manager" (PBM), and then Sterling Winthrop, a US consumer products group, are being wound down, while earnings growth remains firmly in double figures. Pre-tax profits grew 16 per cent (excluding currency factors and exceptionals) to pounds 1.55bn, while earnings per share jumped by an underlying 14 per cent.

The pound's strength could be a short-term drag, given the proportion of sales on the Continent and the US, but probably not one to lose sleep over. The 14 per cent profits growth to pounds 442m notched up in the fourth quarter would have been a chunky 23 per cent without currency effects, but the group reckons the pound at year-end levels would only have shaved 5 per cent from last year's figures.

It is hard to gauge how successful SmithKline's acquisition record has been, given the opacity of the information on offer. Consumer healthcare trading profits rose a respectable 11 per cent to pounds 372m, and the record on brand growth looks decent. The increased global reach provided by Sterling means that brands such as Aquafresh and Panadol have done well, showing strong growth of 24 and 10 per cent respectively last year. That said, the fall in the first nine months of the over-the-counter version of Tagamet suggests SmithKline's abilities in extending the life of its drugs after patent expiry have taken a while to perfect, although competition has been intense.

The picture is fuzzier at Diversified. The group makes much of the fact that it now "manages" the healthcare requirements of 33 million lives, more than twice the 13.8 million at acquisition, and a drug spend of $5.2bn (pounds 3.2bn). But it refuses to reveal profit figures and in the absence of more concrete evidence, it is hard to avoid the conclusion that the same ends could have been achieved more cheaply by other means.

Acquisitions aside, the record remains good. The pounds 580m rationalisation provision of two years ago has delivered gains of pounds 125m and the core drugs business remains highly successful, growing profits 12 per cent to pounds 1.18bn last year. Sales growth should continue in double digits and the group has no big patent expiries until the next century. Assuming Coreg wins US approval for congestive heart failure later this month, new products, nearly a third of total drug sales, should be performing strongly.

Profits of pounds 1.79bn this year would put the shares, up 13p at 894.5p, on a forward p/e of 21. Hold.

Start your day with The Independent, sign up for daily news emails
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Neil Pavier: Management Accountant

£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...

Sheridan Maine: Commercial Accountant

£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...

Laura Norton: Project Accountant

£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...

Day In a Page

Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

Laughter, but no tears, as Letterman takes his bow after 33 years

Veteran talkshow host steps down to plaudits from four presidents
Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

Hozier's 'blasphemous' song takes Novello award

Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

Join the tequila gold rush

The spirit has gone from a cheap shot to a multi-billion pound product
12 best statement wallpapers

12 best statement wallpapers

Make an impact and transform a room with a conversation-starting pattern
Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

Paul Scholes column

Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?